BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer

被引：16
|
作者：
Gross, Amy L. [1 ]
Blot, William J. [2 ]
Visvanathan, Kala [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Clin & Translat Res, Nashville, TN USA
[2] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 320卷 / 06期
关键词：
D O I：
10.1001/jama.2018.8258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：597 / 598
页数：2
相关论文
共 50 条
  • [41] Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
    King, MC
    Marks, JH
    Mandell, JB
    SCIENCE, 2003, 302 (5645) : 643 - 646
  • [42] A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2
    Suman J. Ramus
    Lori S. Friedman
    Simon A. Gayther
    Bruce A.J. Ponder
    Lynda G. Bobrow
    Marco van der Looji
    Janos Papp
    Edith Olah
    Nature Genetics, 1997, 15 : 14 - 15
  • [43] Germline Mutations of BRCA1 and BRCA2 in Korean Breast and/or Ovarian Cancer Families
    Kang, Hio Chung
    Kim, Il-Jin
    Park, Jae-Hyun
    Kwon, Hyuk-Jun
    Won, Yong-Jin
    Heo, Seung Chul
    Lee, Sang-Yon
    Kim, Kyung-Hee
    Shin, Yong
    Noh, Dong Young
    Yang, Dae-Hyun
    Choe, Kuk Jin
    Lee, Bong Hwa
    Kang, Soon Beom
    Park, Jae-Gahb
    HUMAN MUTATION, 2002, 20 (03) : 235
  • [44] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [45] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232
  • [46] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [47] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [48] Cost Effectiveness Analysis of Genetic Testing for Breast and Ovarian Cancer Susceptibility Genes: BRCA1 and BRCA2
    Kaldate, Rajesh
    Huston, Alissa
    McCoy, Heidi
    Cardeiro, Dawn
    Noyes, Katia
    BREAST JOURNAL, 2014, 20 (03): : 325 - 326
  • [49] BRCA1 and BRCA2 mutations in Germany - indications for testing in hereditary breast and ovarian cancer families.
    Schwarz-Boeger, U
    Schmutzler, RK
    Bastert, G
    Bender, HG
    Beckmann, MW
    Caffier, H
    Crohns, C
    Deininger, J
    Dietl, J
    Ditsch, N
    Distler, W
    Estevez-Schwarz, L
    Hepp, H
    Herroeder, N
    Huebbel, V
    Huettner, C
    Jackisch, C
    Jonat, W
    Kandel, M
    Kast, K
    Kaufmann, M
    Krapfl-Gast, AS
    Kreienberg, R
    Kuschel, B
    Kuschel, B
    Luck, H
    Meindl, A
    von Minckwitz, G
    Nestle-Kraemling, C
    Paepke, S
    Prieshof, B
    Rensing, K
    Rhiem, KA
    Schaeffer, MA
    Straub, L
    Untch, M
    Kiechle, T
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S154 - S155
  • [50] Evolution and organization of genetic testing services for breast and ovarian cancer predisposition (BRCA1, BRCA2) in France
    Julian-Reynier, C
    Sévilla, C
    Bourret, P
    Sobol, H
    Nogues, C
    EUROCANCER 2002, 2002, : 205 - 206
12345